With over 8 years of experience in protein biochemistry (4 years graduate plus 4 years post-doctoral), I am passionate about advancing the understanding and treatment of rare diseases. My mission is to leverage my expertise in antibody purification and biochemical characterization to discover and screen novel protein therapeutics that can improve the quality of life of patients. As a postdoctoral scientist at Children's Hospital of Philadelphia (CHOP), I was part of a collaborative and innovative team that is dedicated to finding solutions for complex and challenging medical problems in Hematology.In my post-doctoral research role, I successfully identified and screened monoclonal antibodies targeting factor V, a key protein involved in blood coagulation. Two of these antibodies have shown promising results in enhancing thrombin generation in human hemophilia A plasma. In an internal collaboration to evaluate in vivo efficacy, these antibodies exhibited procoagulant activity in a hemophilia A mouse model. This work has been supported by the National Bleeding Disorder Foundation and was presented at prestigious conferences such as the American Society of Hematology and International Society on Thrombosis and Hemostasis. I have also used various skills and techniques, such as mammalian cell culture, protein purification, Octet/BLI, Western Blotting, ELISA, enzymatic assays, and thrombin generation assays to optimize and validate the lead antibody candidates.